- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials Sponsored by ArQule, Inc. (a wholly owned subsidiary of Merck Sharp and Dohme, a subsidiary of Merck & Co., Inc.)
Total 73 results
-
ArQule, Inc. (a wholly owned subsidiary of Merck...Terminated
-
ArQule, Inc. (a wholly owned subsidiary of Merck...CompletedAdvanced Solid TumorsUnited States, Italy
-
ArQule, Inc. (a wholly owned subsidiary of Merck...CompletedSolid TumorUnited States, Italy
-
ArQule, Inc. (a wholly owned subsidiary of Merck...Completed
-
ArQule, Inc. (a wholly owned subsidiary of Merck...Completed
-
ArQule, Inc. (a wholly owned subsidiary of Merck...CompletedRenal Cell Carcinoma (RCC) | Alveolar Soft Part Sarcoma (ASPS) | Clear Cell Sarcoma (CCS)United States, Canada, United Kingdom
-
ArQule, Inc. (a wholly owned subsidiary of Merck...Completed
-
ArQule, Inc. (a wholly owned subsidiary of Merck...Completed
-
ArQule, Inc. (a wholly owned subsidiary of Merck...No longer availableGrowth Disorders | Proteus Syndrome | PIK3CA-Related Overgrowth Spectrum (PROS)
-
ArQule, Inc. (a wholly owned subsidiary of Merck...TerminatedOvarian Cancer | Endometrial Cancer | Solid TumorsUnited States
-
ArQule, Inc. (a wholly owned subsidiary of Merck...CompletedSolid Tumor | Tumor | Malignant LymphomaUnited States
-
ArQule, Inc. (a wholly owned subsidiary of Merck...CompletedCholangiocarcinoma | Intrahepatic Cholangiocarcinoma | Mixed Hepatocellular CholangiocarcinomaUnited States, Italy
-
ArQule, Inc. (a wholly owned subsidiary of Merck...Withdrawn
-
ArQule, Inc. (a wholly owned subsidiary of Merck...CompletedUnresectable Hepatocellular CarcinomaBelgium, Italy, United States, Germany, Canada
-
ArQule, Inc. (a wholly owned subsidiary of Merck...CompletedCancer, Advanced Solid TumorsUnited Kingdom
-
ArQule, Inc. (a wholly owned subsidiary of Merck...Completed
-
ArQule, Inc. (a wholly owned subsidiary of Merck...Completed
-
ArQule, Inc. (a wholly owned subsidiary of Merck...CompletedAdenocarcinoma | Pancreatic CancerUnited States
-
ArQule, Inc. (a wholly owned subsidiary of Merck...CompletedHead and Neck Neoplasms | Carcinoma, Squamous CellUnited States
-
ArQule, Inc. (a wholly owned subsidiary of Merck...Terminated
-
ArQule, Inc. (a wholly owned subsidiary of Merck...Completed
-
ArQule, Inc. (a wholly owned subsidiary of Merck...CompletedMetastatic Non-Small Cell Lung CancerUnited States
-
ArQule, Inc. (a wholly owned subsidiary of Merck...CompletedNon Small Cell Lung CancerUnited States, Poland, Germany, Russian Federation, Latvia, Ukraine
-
ArQule, Inc. (a wholly owned subsidiary of Merck...CompletedAdvanced Solid TumorsUnited States
-
ArQule, Inc. (a wholly owned subsidiary of Merck...CompletedHepatocellular Carcinoma | CirrhosisSpain, United States, Italy
-
ArQule, Inc. (a wholly owned subsidiary of Merck...CompletedMetastatic Solid Tumors, Refractory/Relapsed Hematologic MalignanciesUnited States
-
ArQule, Inc. (a wholly owned subsidiary of Merck...CompletedAdvanced Solid TumorsUnited States
-
ArQule, Inc. (a wholly owned subsidiary of Merck...Completed
-
ArQule, Inc. (a wholly owned subsidiary of Merck...Completed
-
ArQule, Inc. (a wholly owned subsidiary of Merck...Completed
-
Basilea PharmaceuticaArQule, Inc. (a wholly owned subsidiary of Merck Sharp and Dohme, a subsidiary...CompletedSolid TumorUnited States, Italy
-
Daiichi Sankyo, Inc.ArQule, Inc. (a wholly owned subsidiary of Merck Sharp and Dohme, a subsidiary...TerminatedNon Squamous, Non-small-cell Lung CancerPoland, France, Germany, Italy, Spain, Canada, United States, Argentina, Belgium, Mexico, Australia, Russian Federation, Netherlands, Peru, Brazil, Austria, United Kingdom, Sweden, Czechia, Chile, Denmark, Hungary, Romania
-
Daiichi Sankyo, Inc.ArQule, Inc. (a wholly owned subsidiary of Merck Sharp and Dohme, a subsidiary...CompletedHepatocellular CarcinomaUnited States, France, Italy, Germany, Spain, Switzerland, Belgium, Portugal, Netherlands, Australia, Brazil, Canada, Austria, New Zealand, Sweden, Argentina
-
ArQule, Inc. (a wholly owned subsidiary of Merck...Worldwide Clinical TrialsTerminatedPIK3CA-Related Overgrowth Spectrum (PROS)/Proteus SyndromeUnited States, Australia, Italy, Spain
-
Acceleron Pharma Inc. (a wholly owned subsidiary...CompletedPulmonary Arterial HypertensionUnited States
-
Acceleron Pharma Inc. (a wholly owned subsidiary...TerminatedCharcot-Marie-Tooth Disease | Facioscapulohumeral Muscular DystrophyUnited States, Spain, Canada
-
Acceleron Pharma Inc. (a wholly owned subsidiary...CompletedOsteoporosisUnited States
-
Acceleron Pharma Inc. (a wholly owned subsidiary...TerminatedDuchenne Muscular DystrophyCanada
-
Acceleron Pharma Inc. (a wholly owned subsidiary...Terminated
-
Acceleron Pharma Inc. (a wholly owned subsidiary...TerminatedAdvanced Renal Cell CarcinomaUnited States
-
Acceleron Pharma Inc. (a wholly owned subsidiary...CompletedSquamous Cell Carcinoma of the Head and NeckUnited States
-
Acceleron Pharma Inc. (a wholly owned subsidiary...TerminatedCharcot-Marie-Tooth DiseaseUnited States
-
Acceleron Pharma Inc. (a wholly owned subsidiary...CompletedAdvanced Adult Hepatocellular CarcinomaUnited States
-
Acceleron Pharma Inc. (a wholly owned subsidiary...Completed
-
Acceleron Pharma Inc. (a wholly owned subsidiary...Completed
-
Acceleron Pharma Inc. (a wholly owned subsidiary...CompletedB-ThalassemiaItaly, Greece
-
Acceleron Pharma Inc. (a wholly owned subsidiary...CompletedMultiple Myeloma | Advanced Solid TumorsUnited States
-
Acceleron Pharma Inc. (a wholly owned subsidiary...Completed
-
Acceleron Pharma Inc. (a wholly owned subsidiary...CompletedPulmonary Arterial HypertensionSpain, United States, Israel, Australia, Germany, United Kingdom, France, Brazil
-
Acceleron Pharma Inc. (a wholly owned subsidiary...TerminatedFacioscapulohumeral Muscular DystrophyUnited States, Spain, Canada